Clopidogrel and Ebrantil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clopidogrel (clopidogrel) and Ebrantil (urapidil). Common drug interactions include macular pigmentation among females and blood pressure increased among males.

The phase IV clinical study analyzes what interactions people have when they take Clopidogrel and Ebrantil. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.

What is Ebrantil?

Ebrantil has active ingredients of urapidil. eHealthMe is studying from 1,656 Ebrantil users. Check the latest studies of Ebrantil.

On Jul, 19, 2026

87 people who take Clopidogrel and Ebrantil together, and have interactions are studied.

Clopidogrel and Ebrantil drug interactions.

What are the common drug interactions of Clopidogrel and Ebrantil, by gender? *:

female:

Macular pigmentation (pigmented yellow spot near the centre of the retina)
Myopathy (a muscular disease in which the muscle fibres do not function)
Rash
Reaction to drug excipients
Renal failure acute (rapid kidney dysfunction)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Stent placement
Tongue oedema (swelling of tongue)
Vitreous haemorrhage (intraocular (inside the eye) bleeding)
Abdominal pain upper

male:

Blood pressure increased
General physical health deterioration (weak health status)
Diabetic foot infection
Herpes zoster
Oedema peripheral (superficial swelling)
Tendon pain
Abdominal hernia
Acute abdomen
Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
Blood creatinine increased

What are the common drug interactions of Clopidogrel and Ebrantil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Hemiparesis (weakness on one side of the body)
Hemiplegia (paralysis of one side of the body)
Lacunar infarction (a type of stroke)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Dizziness

50-59:

Atrioventricular block complete (heart block complete)
Atrioventricular block second degree (heart block second degree)
Bradycardia (abnormally slow heart action)
Cardiac disorder
Cardiac failure congestive
Cardiogenic shock (inadequate circulation of blood)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Dizziness
Gangrene (body tissue dies)
Localised infection (infection at the single location)

60+:

Blood pressure increased
Haematochezia (passage of stools containing blood)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Renal disorder (kidney disease)
Somnolence (a state of near-sleep, a strong desire for sleep)
Concomitant disease progression (progress in accompanying disease)
Diabetic foot infection
Oedema peripheral (superficial swelling)
Tendon pain
Abdominal hernia

What are the existing conditions these people have? *

High Blood Pressure: 30 people, 34.48%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 9 people, 10.34%
Percutaneous Coronary Intervention: 7 people, 8.05%
High Blood Cholesterol: 6 people, 6.90%
Diabetes: 6 people, 6.90%
Pain: 5 people, 5.75%
Enlarged Prostate: 5 people, 5.75%
Atherosclerosis (disorder of the arteries): 5 people, 5.75%

* Approximation only. Some reports may have incomplete information.

Do you take Clopidogrel and Ebrantil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously